Emergent BioSolutions to Participate in Upcoming Investor Conferences
Rhea-AI Summary
Emergent BioSolutions (NYSE: EBS) has announced its participation in multiple upcoming investor conferences in May and June 2025. The company's executive management team will attend:
- RBC Global Healthcare Conference in New York (May 20) featuring a fireside chat at 3:35 pm ET
- Goldman Sachs Leveraged Finance Conference in Dana Point, California (May 29)
- Benchmark's 5th Annual Healthcare House Call Virtual Investor Conference (May 29)
- Jefferies Global Healthcare Conference in New York (June 5) with a presentation at 1:25 pm ET
Virtual attendance options are available for select events, and presentation replays will be accessible through Emergent's website investor page.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, EBS declined 4.08%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
GAITHERSBURG, Md., May 14, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of its executive management team will participate in the following investor conferences:
- RBC Global Healthcare Conference (New York, New York)
Fireside chat on Tuesday, May 20 at 3:35 pm ET
Virtual attendees can participate via webcast
- Goldman Sachs Leveraged Finance Conference, May 29, 2025 (Dana Point, California)
- Benchmark’s 5th Annual Healthcare House Call Virtual Investor Conference
Presentation on Thursday, May 29
- Jefferies Global Healthcare Conference (New York, New York)
Presentation on Thursday, June 5 at 1:25 pm ET
Virtual attendees can participate via webcast
A replay of the presentations can be accessed from the Investors page of Emergent’s website.
About Emergent BioSolutions
At Emergent, our mission is to protect and save lives. For over 25 years, we’ve been at work preparing those entrusted with protecting public health. We deliver protective and life-saving solutions for health threats like smallpox, mpox, botulism, Ebola, anthrax and opioid overdose emergencies. To learn more about how we help prepare communities around the world for today’s health challenges and tomorrow’s threats, visit our website and follow us on LinkedIn, X, Instagram, Apple Podcasts and Spotify.
Investor Contact:
Richard S. Lindahl
Executive Vice President, CFO
lindahlr@ebsi.com
Media Contact:
Assal Hellmer
Vice President, Communications
mediarelations@ebsi.com
FAQ
Which investor conferences will Emergent BioSolutions (EBS) attend in May-June 2025?
When is Emergent BioSolutions' (EBS) presentation at the RBC Global Healthcare Conference 2025?
How can investors access Emergent BioSolutions' (EBS) conference presentations?
What time is Emergent BioSolutions' (EBS) presentation at the Jefferies Global Healthcare Conference 2025?
